Expression of Matrix Metalloproteinases and Theirs Tissue Inhibitors in Fibroblast Cultures and Colo-829 and SH-4 Melanoma Cultures After Photodynamic Therapy

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-02-13

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.5772/54935
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Porphyrin with amino acid moieties: a tumor photosensitizer.

  2008cited by this paper
• Pair correlation function analysis of 5-(4-hexadecyloxyphenyl)-10,15,20-tri(4-pyridyl)porphyrin and 5-(4-methoxycarbonylphenyl)-10,15,20-tri(4-pyridyl)porphyrin

  2008cited by this paper
• Tailor-made approach to photodynamic therapy in the treatment of cancer based on Bcl-2 photodamage.

  2008cited by this paper
• Bactericidal effect of photodynamic therapy against methicillin-resistant Staphylococcus aureus strain with the use of various porphyrin photosensitizers.

  2007cited by this paper
• Photodynamic therapy for recurrent hyphema after proton beam radiotherapy of iris melanoma

  2007cited by this paper
• The Role of Matrix Metalloproteinases (MMPs) in Human Caries

  2006influential reference
• Spectroscopic properties and photodynamic effects of new lipophilic porphyrin derivatives: efficacy, localisation and cell death pathways.

  2006cited by this paper
• Systemic Antitumor Effect of Intratumoral Injection of Dendritic Cells in Combination with Local Photodynamic Therapy

  2006cited by this paper
• Measurement of Matrix Metalloproteinases in Serum of Patients with Melanoma: Snarled in Technical Pitfalls

  2005cited by this paper
• Role of matrix metalloproteinases in melanoma cell invasion.

  2005influential reference
• Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.

  2004cited by this paper
• Photodynamic therapy with chlorin e6 for skin metastases of melanoma

  2004cited by this paper
• Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

  2004cited by this paper
• Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation.

  2003cited by this paper
• Identification of activated matrix metalloproteinase‐2 (MMP‐2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography

  2002cited by this paper
• Fibroblasts enhance the invasive capacity of melanoma cells in vitro

  2002influential reference
• New functions for the matrix metalloproteinases in cancer progression

  2002influential reference
• High expression levels of collagenase‐1 and stromelysin‐1 correlate with shorter disease‐free survival in human metastatic melanoma

  2002influential reference
• CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

  2002cited by this paper
• Human macrophage metalloelastase gene expression in colorectal carcinoma and its clinicopathologic significance

  2001cited by this paper
• Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery.

  2001influential reference
• Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.

  2001cited by this paper
• Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo

  2001cited by this paper
• Inflammatory Cells and Cancer

  2001cited by this paper
• Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1.

  2001cited by this paper
• Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells

  2001cited by this paper
• Cleavage and Shedding of E-cadherin after Induction of Apoptosis*

  2001cited by this paper
• Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1*

  2001cited by this paper
• Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices.

  2001cited by this paper
• Gelatinase B: a tuner and amplifier of immune functions.

  2001cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• PECAM‐1 shedding during apoptosis generates a membrane‐anchored truncated molecule with unique signaling characteristics

  2001cited by this paper
• Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling*

  2001cited by this paper
• Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor

  2001cited by this paper
• Generation and degradation of human endostatin proteins by various proteinases

  2000cited by this paper
• The contradictions of the insulin-like growth factor 1 receptor

  2000cited by this paper
• Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

  2000cited by this paper
• Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

  2000cited by this paper
• TIMP-2 Is Required for Efficient Activation of proMMP-2 in Vivo *

  2000cited by this paper
• Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase.

  2000cited by this paper
• The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis.

  1999cited by this paper
• Matrix metalloproteinases in tumour invasion and metastasis

  1999cited by this paper
• Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

  1999cited by this paper
• Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay.

  1998cited by this paper
• Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases.

  1998cited by this paper
• Matrix metalloproteinases generate angiostatin: effects on neovascularization.

  1998cited by this paper
• An essential role for ectodomain shedding in mammalian development.

  1998influential reference
• Mammary carcinoma cells over-expressing tissue inhibitor of metalloproteinases-1 show enhanced vascular endothelial growth factor expression.

  1998cited by this paper
• Mammary carcinoma cells over‐expressing tissue inhibitor of metalloproteinases‐1show vascular endothelial growth factor expression

  1998cited by this paper
• Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins.

  1998cited by this paper
• Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis

  1998cited by this paper
• Identification of Insulin-like Growth Factor-binding Protein-1 as a Potential Physiological Substrate for Human Stromelysin-3*

  1997cited by this paper
• Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.

  1997cited by this paper
• Stromal Expression of MMP‐9 and Urokinase Receptor Is Inversely Associated with Liver Metastasis and with Infiltrating Growth in Human Colorectal Cancer: A Novel Approach from Immune/Inflammatory Aspect

  1997cited by this paper
• Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1.

  1997cited by this paper
• Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.

  1997cited by this paper
• Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion.

  1997cited by this paper
• Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene

  1996cited by this paper
• Epithelial-mesenchymal transitions in cancer progression.

  1996cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• MATRIX METALLOPROTEINASE‐2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUE

  1996cited by this paper
• Gelatinase A activity directly modulates melanoma cell adhesion and spreading.

  1995influential reference
• Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.

  1995cited by this paper
• The alpha v beta 6 integrin promotes proliferation of colon carcinoma cells through a unique region of the beta 6 cytoplasmic domain

  1994cited by this paper
• Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2).

  1994cited by this paper
• Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression [published erratum appears in J Cell Biol 1996 Feb;132(4):following 752]

  1994cited by this paper

• New panel of biomarkers to discriminate between amelanotic and melanotic metastatic melanoma

  2023cites this paper
• Kunitz type protease inhibitor from the canine tapeworm as a potential therapeutic for melanoma

  2019cites this paper
• Applicability of Plant Extracts in Preclinical Studies of Melanoma: A Systematic Review

  2018cites this paper
• Investigation of the role of MMP3 -1171insA polymorphism in cutaneous malignant melanoma – a preliminary study

  2014cites this paper